Sunzen Group Berhad (KLSE: SUNZEN)

Market Cap	241.11M
Revenue (ttm)	95.12M
Net Income (ttm)	6.03M
Shares Out	777.78M
EPS (ttm)	0.01
PE Ratio	42.27
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	965,100
Average Volume	977,420
Open	0.310
Previous Close	0.310
Day's Range	0.305 - 0.315
52-Week Range	0.250 - 0.400
Beta	1.85
RSI	45.22
Earnings Date	Feb 28, 2025

About Sunzen Group Berhad

Sunzen Group Berhad engages in the biotechnology research and development, manufacturing, and marketing of animal feed supplement products in Malaysia, China, Singapore, and internationally. It operates through three segments: Animal Health, Human Health, and Loan Financing. The company provides veterinary machines, pharmaceutical, chemical products, animal health products and equipment, laboratory services, and beauty and cosmetic products. It also manufactures and sells traditional Chinese medicine, herbal health foods, beverages, and other p...

• Industry: Pharmaceutical Preparations
• Founded: 1998
• Country: Malaysia
• Stock Exchange: Bursa Malaysia
• Ticker Symbol: SUNZEN

Financial Performance

In 2024, Sunzen Group Berhad's revenue was 95.12 million, a decrease of -3.07% compared to the previous year's 98.13 million. Earnings were 6.03 million, a decrease of -11.35%.